AnaptysBio, Inc. (ANAB) Profit Margins
Over the twelve months to 2026-06-30, AnaptysBio, Inc. (ANAB) had net margin 82.4%, free cash flow margin 7.6%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ANABAnaptysBio, Inc.Follow ANAB — free
—
Price chart with a free account
- Market cap
- 1.5B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — | — | 87.4% | — | — | |
| Operating margin | -287.8% | -1334.4% | -1342.9% | -31.8% | -89.9% | -1119.4% | -958.3% | 72.5% | 96.7% | — | |
| Net margin | -300.7% | -1233.1% | -1216.7% | -26.6% | -91.5% | -1251.3% | -953.7% | -159.1% | -5.6% | 82.4% | |
| FCF margin | -197.3% | -991.4% | -879.0% | -19.6% | -74.8% | -718.9% | -708.8% | -148.3% | 8.4% | 7.6% |
USD millions · SEC XBRL
AnaptysBio, Inc. — questions
- What is AnaptysBio, Inc.'s net profit margin?
- 82.4% over the twelve months to 2026-06-30.
Every figure on this page comes from AnaptysBio, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.